Karahan Mehmet, Kervan Ümit, Kocabeyoğlu Sinan Sabit, Sert Doğan Emre, Akdi Mustafa, Yılmaz Abdülkadir, Koçak Can, Çatav Zeki
Department of Cardiovascular Surgery, Ankara City Hospital, Ankara, Türkiye.
Turk Gogus Kalp Damar Cerrahisi Derg. 2023 Jan 30;31(1):37-44. doi: 10.5606/tgkdc.dergisi.2023.23370. eCollection 2023 Jan.
The aim of this study was to compare our experience of left ventricular assist device implantation via minimally invasive left thoracotomy with off-pump versus on-pump technique.
Between June 2013 and April 2020, nine patients (8 males, 1 female; mean age: 47±11.9 years; range, 30 to 61 years) who underwent off-pump left ventricular assist device implantation and nine patients (8 males, 1 female; mean age: 47±11.4 years; range, 29 to 60 years) who underwent on-pump minimally invasive left thoracotomy were retrospectively analyzed. Postoperative outcomes and mid-term results of both groups were evaluated.
Outflow graft was anastomosed to the ascending aorta with J-sternotomy in all patients. The median duration of intubation and intensive care unit stay were one (IQR: 1.5) day and eight (IQR: 6.5) days in the off-pump group, respectively and one (IQR: 0) day and seven (IQR: 7) days in the on-pump group, respectively. Intra-aortic balloon pump was needed during the weaning of cardiopulmonary bypass in one (11%) of the patients in both groups. Postoperative right ventricular failure was observed in two (22%) patients in the offpump group who were treated medically and recovered. There was no need for revision due to bleeding or postoperative extracorporeal membrane oxygenator implantation in either group. In the off-pump group, three patients underwent heart transplantation after median 854 (IQR: 960) days. Three patients died one month, two and four years after implantation. Three patients were still alive with left ventricular assist device and were being uneventfully followed for 365, 400, and 700 days after implantation.
Off-pump technique is safe and feasible option for implantation of left ventricular assist device via minimally invasive left thoracotomy.
本研究的目的是比较我们通过微创左胸切口采用非体外循环与体外循环技术植入左心室辅助装置的经验。
回顾性分析2013年6月至2020年4月期间接受非体外循环左心室辅助装置植入的9例患者(8例男性,1例女性;平均年龄:47±11.9岁;范围30至61岁)和接受体外循环微创左胸切口的9例患者(8例男性,1例女性;平均年龄:47±11.4岁;范围29至60岁)。评估两组的术后结果和中期结果。
所有患者均采用J形胸骨切开术将流出道移植物吻合至升主动脉。非体外循环组的插管中位持续时间和重症监护病房停留时间分别为1天(四分位间距:1.5)和8天(四分位间距:6.5),体外循环组分别为1天(四分位间距:0)和7天(四分位间距:7)。两组各有1例(11%)患者在体外循环撤机期间需要主动脉内球囊泵。非体外循环组有2例(22%)患者出现术后右心室衰竭,经药物治疗后康复。两组均无需因出血或术后植入体外膜肺氧合进行翻修。在非体外循环组中,3例患者在中位854天(四分位间距:960)后接受了心脏移植。3例患者在植入后1个月、2年和4年死亡。3例患者仍带着左心室辅助装置存活,植入后分别顺利随访365天、400天和700天。
非体外循环技术是通过微创左胸切口植入左心室辅助装置的一种安全可行的选择。